Angiogenesis Modulations In Health And Disease: Practical Applications Of Pro- And Anti-angiogenesis Targets by Shaker A. MousaAngiogenesis Modulations In Health And Disease: Practical Applications Of Pro- And Anti-angiogenesis Targets by Shaker A. Mousa

Angiogenesis Modulations In Health And Disease: Practical Applications Of Pro- And Anti…

byShaker A. MousaEditorPaul J. Davis

Paperback | June 23, 2015

Pricing and Purchase Info

$217.84 online 
$248.50 list price save 12%
Earn 1,089 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets.

Title:Angiogenesis Modulations In Health And Disease: Practical Applications Of Pro- And Anti…Format:PaperbackDimensions:206 pages, 23.5 × 15.5 × 0.02 inPublished:June 23, 2015Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401785155

ISBN - 13:9789401785150

Look for similar items by category:

Reviews

Table of Contents

Preface. 1. Angiogenesis assays: an appraisal of current techniques. 2. Survey of pro-angiogenesis strategies. 3. Angiogenesis modulation by arachidonic acid - derived lipids: positive and negative regulators of angiogenesis. 4. Pro-angiogenic activity of thyroid hormone analogues: Mechanisms, physiology and clinical prospects. 5. Actions of steroids and peptide hormones on angiogenesis. 6. Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis modulation. 7. Catecholamine neurotransmitters: an angiogenic switch in the tumor microenvironment. 8. Impact of nanotechnology on therapeutic angiogenesis. 9. Survey of anti-angiogenesis strategies. 10. Tetraiodothyroacetic acid (tetrac), nanotetrac and anti-Angiogenesis. 11. Integrin antagonists and angiogenesis. 12. Anti-angiogenesis therapy as an adjunct to chemotherapy in oncology. 13. Anti-vegf strategies in ocular angiogenesis- mediated disorders, with special emphasis on age-related macular degeneration. 14. Application of nanotechnology to targeting tumor angiogenesis for therapeutic benefit. 15. Biomarkers of response and resistance to anti-angiogenic treatment.16. Speculations on new directions in which angiogenesis may proceed. Index.